177 related articles for article (PubMed ID: 37451426)
21. BECN1 and BIM interactions with MCL-1 determine fludarabine resistance in leukemic B cells.
Sharma A; Singh K; Mazumder S; Hill BT; Kalaycio M; Almasan A
Cell Death Dis; 2013 May; 4(5):e628. PubMed ID: 23681223
[TBL] [Abstract][Full Text] [Related]
22. Introduction of long non-coding RNAs to regulate autophagy-associated therapy resistance in cancer.
Wang Y; Liu Z; Xu Z; Shao W; Hu D; Zhong H; Zhang J
Mol Biol Rep; 2022 Nov; 49(11):10761-10773. PubMed ID: 35810239
[TBL] [Abstract][Full Text] [Related]
23. Targeting autophagy to overcome drug resistance in cancer therapy.
Kumar A; Singh UK; Chaudhary A
Future Med Chem; 2015 Aug; 7(12):1535-42. PubMed ID: 26334206
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological Modulation of Apoptosis and Autophagy in Pancreatic Cancer Treatment.
Selvarajoo N; Stanslas J; Islam MK; Sagineedu SR; Lian HK; Lim JCW
Mini Rev Med Chem; 2022; 22(20):2581-2595. PubMed ID: 35331093
[TBL] [Abstract][Full Text] [Related]
25. Autophagy is a therapeutic target in anticancer drug resistance.
Chen S; Rehman SK; Zhang W; Wen A; Yao L; Zhang J
Biochim Biophys Acta; 2010 Dec; 1806(2):220-9. PubMed ID: 20637264
[TBL] [Abstract][Full Text] [Related]
26. RCE‑4, a potential anti‑cervical cancer drug isolated from Reineckia carnea, induces autophagy via the dual blockade of PI3K and ERK pathways in cervical cancer CaSki cells.
Xiang W; Zhang RJ; Jin GL; Tian L; Cheng F; Wang JZ; Xing XF; Xi W; Tang SJ; Chen JF
Int J Mol Med; 2020 Jan; 45(1):245-254. PubMed ID: 31746346
[TBL] [Abstract][Full Text] [Related]
27. Autophagy-mediating microRNAs in cancer chemoresistance.
Jing Y; Liang W; Liu J; Zhang L; Wei J; Yang J; Zhang Y; Huang Z
Cell Biol Toxicol; 2020 Dec; 36(6):517-536. PubMed ID: 32875398
[TBL] [Abstract][Full Text] [Related]
28. Annexin A1 induces oxaliplatin resistance of gastric cancer through autophagy by targeting PI3K/AKT/mTOR.
Ren J; Hu Z; Niu G; Xia J; Wang X; Hong R; Gu J; Wang D; Ke C
FASEB J; 2023 Mar; 37(3):e22790. PubMed ID: 36786694
[TBL] [Abstract][Full Text] [Related]
29. Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway.
Kumar D; Shankar S; Srivastava RK
Cancer Lett; 2014 Feb; 343(2):179-89. PubMed ID: 24125861
[TBL] [Abstract][Full Text] [Related]
30. Up-regulated autophagy by endogenous high mobility group box-1 promotes chemoresistance in leukemia cells.
Yang L; Yu Y; Kang R; Yang M; Xie M; Wang Z; Tang D; Zhao M; Liu L; Zhang H; Cao L
Leuk Lymphoma; 2012 Feb; 53(2):315-22. PubMed ID: 21864037
[TBL] [Abstract][Full Text] [Related]
31. c-Met overexpression contributes to the acquired apoptotic resistance of nonadherent ovarian cancer cells through a cross talk mediated by phosphatidylinositol 3-kinase and extracellular signal-regulated kinase 1/2.
Tang MK; Zhou HY; Yam JW; Wong AS
Neoplasia; 2010 Feb; 12(2):128-38. PubMed ID: 20126471
[TBL] [Abstract][Full Text] [Related]
32. S100A8 contributes to drug resistance by promoting autophagy in leukemia cells.
Yang M; Zeng P; Kang R; Yu Y; Yang L; Tang D; Cao L
PLoS One; 2014; 9(5):e97242. PubMed ID: 24820971
[TBL] [Abstract][Full Text] [Related]
33. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-mediated autophagic signaling networks and cancer chemoresistance.
Pan B; Yi J; Song H
Cancer Biother Radiopharm; 2013 Oct; 28(8):573-8. PubMed ID: 23841710
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Xue HQ; Sun L; Sun C; Feng W; Guo SB
Oncol Rep; 2020 Apr; 43(4):1169-1186. PubMed ID: 32323781
[TBL] [Abstract][Full Text] [Related]
36. Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy.
Xu Z; Han X; Ou D; Liu T; Li Z; Jiang G; Liu J; Zhang J
Appl Microbiol Biotechnol; 2020 Jan; 104(2):575-587. PubMed ID: 31832711
[TBL] [Abstract][Full Text] [Related]
37. Alisertib Induces Cell Cycle Arrest, Apoptosis, Autophagy and Suppresses EMT in HT29 and Caco-2 Cells.
Ren BJ; Zhou ZW; Zhu DJ; Ju YL; Wu JH; Ouyang MZ; Chen XW; Zhou SF
Int J Mol Sci; 2015 Dec; 17(1):. PubMed ID: 26729093
[TBL] [Abstract][Full Text] [Related]
38. Full-coverage regulations of autophagy by ROS: from induction to maturation.
Zhou J; Li XY; Liu YJ; Feng J; Wu Y; Shen HM; Lu GD
Autophagy; 2022 Jun; 18(6):1240-1255. PubMed ID: 34662529
[TBL] [Abstract][Full Text] [Related]
39. DNA-dependent protein kinase regulates lysosomal AMP-dependent protein kinase activation and autophagy.
Puustinen P; Keldsbo A; Corcelle-Termeau E; Ngoei K; Sønder SL; Farkas T; Kaae Andersen K; Oakhill JS; Jäättelä M
Autophagy; 2020 Oct; 16(10):1871-1888. PubMed ID: 31983282
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy.
Tsurutani J; West KA; Sayyah J; Gills JJ; Dennis PA
Cancer Res; 2005 Sep; 65(18):8423-32. PubMed ID: 16166321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
